Josef T Prchal

21PUBLICATIONS
67CO-AUTHORS
Molecular targetsEnvironmental epidemiologyEcohydrologyGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Mar 05, 2026
Selinexor plus ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis: a multicenter, open-label, phase 1 study.

Haris Ali, Sanjay Ram Mohan, Ashwin Kishtagari

|Jan 23, 2026
Autosomal Dominant Erythrocytosis Caused by Non-Renal Erythropoietin (EPO) Due to EPO c.-136 G>A Germline Mutation.

Lucie Lanikova, Dusan Hrckulak, Veronika Zimolova

|Jul 30, 2025
History of Thrombosis at High Altitude Associates With Increased Erythropoietin.

Ricardo Amaru, Josef Prchal, Mireya Carrasco

|Feb 19, 2025
Alternatively spliced NFKB1 transcripts enriched in Andean Aymara modulate inflammation, HIF and hemoglobin.

Jihyun Song, Seonggyun Han, Ricardo Amaru

|Apr 17, 2024
Novel germline JAK2R715T mutation causing PV-like erythrocytosis in 3 generations. Amelioration by Ropeg-Interferon.

Jihyun Song, Lucie Lanikova, Soo Jin Kim

|Jul 12, 2023
Increased transferrin protects from thrombosis in Chuvash erythrocytosis.

Binal N Shah, Xu Zhang, Adelina I Sergueeva

Pageof 4

Frequent Collaborators

7 joint publications

Jihyun Song

4 joint publications

Lucie Lanikova

3 joint publications

Victor R Gordeuk

3 joint publications

Brandi N Reeves